Skip to content

Clinical trials

Completed Nervous System Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nervous System Diseases Status: Completed Country / region: United States Clear all

174 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20044
20051
20062
20071
20084
20094
20108
201111
20123
201311
201412
201510
201610
201712
201820
201914
20207
20219
20229
20236
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed174

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Neurological Disorders and Stroke (NINDS)12
Otsuka Pharmaceutical Development & Commercialization, Inc.6
AbbVie5
GenSight Biologics4
National Institute of Mental Health (NIMH)4
Vanderbilt University Medical Center4
Alkahest, Inc.3
Auspex Pharmaceuticals, Inc.3
Massachusetts General Hospital3
Northwestern University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nervous System Diseases174
Central Nervous System Diseases54
Brain Diseases44
Neurodegenerative Diseases30
Neurologic Manifestations25
Mental Disorders20
Movement Disorders18
Genetic Diseases, Inborn17
Musculoskeletal Diseases16
Neuromuscular Diseases16

Trials

Showing 1 to 25 of 174. Each trial links to its page on Pharma Observatory.

74 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.